Patient-reported outcomes predict aromatase inhibitor adherence

by SWOGCredit: CC0 Public DomainIf you want to predict which breast cancer patients will most likely stop taking aromatase inhibitors, check out their own responses to the health questions patients co

Updated on: December 22,2023

Patient-reported outcomes predict aromatase inhibitor adherence

by SWOGCredit: CC0 Public DomainIf you want to predict which breast cancer patients will most likely stop taking aromatase inhibitors, check out their own responses to the health questions patients co

Updated on:December 22,2023

Locally advanced cervical cancer: Better odds using personalized brachytherapy

byMedical University of ViennaCredit: AI-generated imageCervical cancer is the cancer with the fourth highest mortality rate among women worldwide. Locally advanced cervical cancer (LACC) is tre

Updated on: December 26,2023

Locally advanced cervical cancer: Better odds using personalized brachytherapy

byMedical University of ViennaCredit: AI-generated imageCervical cancer is the cancer with the fourth highest mortality rate among women worldwide. Locally advanced cervical cancer (LACC) is tre

Updated on:December 26,2023

Researchers uncover new clues to origins of the most common pediatric kidney cancer

by Children's Hospital Los AngelesSIX2+CITED1+ cells in hFK and WT have different transcriptional signatures. A,B) Periodic acid Schiff (PAS, left, whole image) and H&E (right, close-up i

Updated on: February 20,2024

Researchers uncover new clues to origins of the most common pediatric kidney cancer

by Children's Hospital Los AngelesSIX2+CITED1+ cells in hFK and WT have different transcriptional signatures. A,B) Periodic acid Schiff (PAS, left, whole image) and H&E (right, close-up i

Updated on:February 20,2024

Deep learning–based virtual staining of tissue facilitates rapid assessment of breast cancer biomarker

byUCLA Engineering Institute for Technology AdvancementVirtual HER2 staining of unlabeled breast tissue sections using deep learning. Credit: Ozcan Lab @ UCLA.Breast cancer is one the leading ca

Updated on: December 25,2023

Deep learning–based virtual staining of tissue facilitates rapid assessment of breast cancer biomarker

byUCLA Engineering Institute for Technology AdvancementVirtual HER2 staining of unlabeled breast tissue sections using deep learning. Credit: Ozcan Lab @ UCLA.Breast cancer is one the leading ca

Updated on:December 25,2023

Immune cells trained to hunt tumors after scientists plant synthetic 'flags' on cancer

Updated on: June 15,2025

Immune cells trained to hunt tumors after scientists plant synthetic 'flags' on cancer

Updated on:June 15,2025

Falling PSA levels found to predict longer survival in prostate cancer patients at high risk of metastases

byWolters Kluwer HealthTwelve-month landmark analysis of overall survival (OS) by prostate-specific antigen (PSA) decline subgroup for enzalutamide-treated men. Data cutoff: October 15, 2019. Cr

Updated on: January 02,2024

Falling PSA levels found to predict longer survival in prostate cancer patients at high risk of metastases

byWolters Kluwer HealthTwelve-month landmark analysis of overall survival (OS) by prostate-specific antigen (PSA) decline subgroup for enzalutamide-treated men. Data cutoff: October 15, 2019. Cr

Updated on:January 02,2024

Genetic study provides most comprehensive map of risk to date of breast cancer risk

byUniversity of CambridgeCredit: CC0 Public DomainA major international study of the genetics of breast cancer has identified more than 350 DNA 'errors' that increase an individual's

Updated on: December 20,2023

Genetic study provides most comprehensive map of risk to date of breast cancer risk

byUniversity of CambridgeCredit: CC0 Public DomainA major international study of the genetics of breast cancer has identified more than 350 DNA 'errors' that increase an individual's

Updated on:December 20,2023

A quicker answer on cancer, with waits cut from 84 days to 6

bySwansea UniversityCredit: CC0 Public DomainA rapid diagnosis centre has cut waiting times for patients with non-specific symptoms who may have cancer from 84 days to 6, and costs less than cur

Updated on: December 22,2023

A quicker answer on cancer, with waits cut from 84 days to 6

bySwansea UniversityCredit: CC0 Public DomainA rapid diagnosis centre has cut waiting times for patients with non-specific symptoms who may have cancer from 84 days to 6, and costs less than cur

Updated on:December 22,2023

Pictures of Melanoma and Other Skin Cancers

Pictures of Melanoma and Other Skin CancersSkin cancer pictures can help you spot abnormalities that warrant evaluationByAngelica BottaroUpdated on October 28, 2023Medically reviewed

Updated on: January 28,2024

Pictures of Melanoma and Other Skin Cancers

Pictures of Melanoma and Other Skin CancersSkin cancer pictures can help you spot abnormalities that warrant evaluationByAngelica BottaroUpdated on October 28, 2023Medically reviewed

Updated on:January 28,2024

A solid vaccine for liquid tumors

byHarvard UniversityCredit: CC0 Public DomainAcute myeloid leukemia (AML) is a deadly blood cancer that originates in the bone marrow and kills most of its victims within five years. Chemotherap

Updated on: December 20,2023

A solid vaccine for liquid tumors

byHarvard UniversityCredit: CC0 Public DomainAcute myeloid leukemia (AML) is a deadly blood cancer that originates in the bone marrow and kills most of its victims within five years. Chemotherap

Updated on:December 20,2023

Researchers uncover new vulnerability in kidney cancer

by Deborah Wormser,UT Southwestern Medical CenterFrom left: Drs. Lianxin Hu, Qing Zhang, and Haibiao Xie Credit: UTSWA UT Southwestern researcher led a team that identified a new vulnerability i

Updated on: December 22,2023

Researchers uncover new vulnerability in kidney cancer

by Deborah Wormser,UT Southwestern Medical CenterFrom left: Drs. Lianxin Hu, Qing Zhang, and Haibiao Xie Credit: UTSWA UT Southwestern researcher led a team that identified a new vulnerability i

Updated on:December 22,2023

A top-down study of isogenic human non-metastatic and metastatic colorectal cancer cell lines

by Bob Yirka , Medical XpressSchematic of the experimental design. (A) Schematic design of the TDP study of metastatic (SW620) and nonmetastatic (SW480) CRC cells using CZE-ESI-MS/MS and LC-CZE-ESI-MS

Updated on: December 20,2023

A top-down study of isogenic human non-metastatic and metastatic colorectal cancer cell lines

by Bob Yirka , Medical XpressSchematic of the experimental design. (A) Schematic design of the TDP study of metastatic (SW620) and nonmetastatic (SW480) CRC cells using CZE-ESI-MS/MS and LC-CZE-ESI-MS

Updated on:December 20,2023